Sreborn Skin Clinic Hongdae

Looking for a Mounjaro weight loss program in Seoul? Sreborn Skin Clinic Hongdae provides individualized medical consultations, prescription assessment, progress monitoring, and lifestyle guidance for patients considering tirzepatide.

Mounjaro contains tirzepatide, a medication that acts on GIP and GLP-1 receptors. Its approved indications may vary by country, so prescription decisions must follow Korean regulations, current product labeling, and an individual medical assessment.

What Is Mounjaro?

Mounjaro is a prescription injectable medication containing tirzepatide.

Tirzepatide influences appetite, fullness, blood-glucose regulation, and gastric emptying. This may support weight reduction in eligible patients when combined with appropriate nutrition, physical activity, and ongoing medical care.

Mounjaro is not a localized fat-dissolving injection.

What Does a Mounjaro Program Include?

A personalized program may include:

• Initial medical consultation
• Height, weight, and body-composition assessment
• Review of weight-loss history
• Medication eligibility screening
• Prescription when medically appropriate
• Injection education
• Gradual dose escalation
• Side-effect monitoring
• Nutrition and activity guidance
• Muscle-preservation planning
• Long-term weight-maintenance support

Treatment availability depends on medical eligibility, local approval, and medication supply.

Who May Be Eligible?

Eligibility may be influenced by:

• Body mass index
• Weight-related health conditions
• Type 2 diabetes history
• Previous weight-loss attempts
• Current medications
• Gastrointestinal health
• Pancreatic or gallbladder history
• Kidney function
• Pregnancy plans
• Personal and family medical history

Mounjaro should not be prescribed simply because a patient wants rapid cosmetic weight loss.

Medical Assessment Before Treatment

Before prescribing tirzepatide, the clinic may review:

• Current height and weight
• Waist circumference
• Body composition
• Blood pressure
• Weight history
• Eating and activity patterns
• Current prescriptions
• Diabetes medications
• Previous GLP-1 treatment
• Pancreatic and gallbladder conditions
• Kidney and liver health
• Thyroid-related medical history
• Pregnancy or breastfeeding status

Blood testing or additional medical evaluation may be recommended.

How Is Mounjaro Used?

Mounjaro is administered by subcutaneous injection according to a prescribed schedule.

Treatment generally begins at a lower dose and increases gradually when tolerated. Patients should not increase, reduce, combine, stop, or restart doses without guidance from their prescribing clinician.

Mounjaro Injection Areas

Appropriate injection areas may include:

• Abdomen
• Thigh
• Upper arm

Injection sites should be rotated. The medication must be stored, handled, and administered according to its official instructions.

How Does Tirzepatide Support Weight Loss?

Tirzepatide activates GIP and GLP-1 receptors.

This may help patients:

• Feel full earlier
• Remain full longer
• Experience reduced appetite
• Reduce food intake
• Improve blood-glucose regulation
• Follow a structured calorie-reduction plan

Responses vary, and medication does not eliminate the need for sustainable lifestyle changes.

How Much Weight Can I Lose?

Weight-loss outcomes differ significantly.

Progress may be affected by:

• Starting weight
• Medical conditions
• Medication tolerance
• Dose progression
• Nutrition
• Physical activity
• Sleep
• Treatment adherence
• Individual biological response

No specific number of kilograms or percentage of weight loss can be guaranteed.

Protecting Muscle During Treatment

Weight reduction can involve loss of both fat and lean muscle.

A structured program may emphasize:

• Adequate protein intake
• Resistance exercise
• Appropriate calorie intake
• Gradual weight reduction
• Body-composition monitoring
• Review of weakness or fatigue

Preserving muscle supports strength, metabolism, function, and body contours.

Common Mounjaro Side Effects

Common reactions may include:

• Nausea
• Diarrhea
• Reduced appetite
• Vomiting
• Constipation
• Indigestion
• Abdominal discomfort
• Injection-site reactions

Side effects may become more noticeable after starting treatment or increasing the dose. Patients should review the current official prescribing information before treatment. Mounjaro Prescribing Information

Serious Risks and Warning Signs

Potentially serious complications may include:

• Pancreatitis
• Severe gastrointestinal reactions
• Gallbladder problems
• Dehydration
• Kidney injury
• Serious allergic reactions
• Low blood sugar with certain diabetes medications
• Diabetic retinopathy complications
• Pulmonary aspiration during anesthesia or deep sedation

Seek urgent medical care for persistent severe abdominal pain, breathing difficulty, facial swelling, fainting, severe dehydration, or other serious symptoms.

Thyroid Tumor Warning

Mounjaro carries a warning related to thyroid C-cell tumors observed in animal studies.

It is contraindicated for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Report a neck lump, persistent hoarseness, swallowing difficulty, or breathing difficulty promptly.

Mounjaro and Oral Birth Control

Tirzepatide can affect the absorption and effectiveness of oral hormonal contraceptives, particularly after beginning treatment or increasing the dose.

Patients using birth-control pills should discuss temporary additional or alternative contraception with their prescribing clinician.

Mounjaro Before Surgery or Sedation

Tirzepatide delays gastric emptying, which may affect procedures involving general anesthesia or deep sedation.

Tell the surgeon and anesthesiologist that you use Mounjaro before:

• Surgery
• Endoscopy
• Sedated dental treatment
• Plastic surgery
• Any procedure involving deep sedation

Do not stop the medication independently; follow the treating medical team’s instructions.

Who Should Not Use Mounjaro?

Treatment may be unsuitable for patients with:

• Pregnancy or planned pregnancy
• Serious hypersensitivity to tirzepatide
• Personal or family history of medullary thyroid carcinoma
• Multiple Endocrine Neoplasia syndrome type 2
• Certain severe gastrointestinal disorders
• Selected pancreatic or gallbladder conditions
• Significant dehydration
• Certain medication interactions

Suitability must be determined through an individual medical assessment.

Mounjaro vs. Wegovy

Both are prescription medications but contain different active ingredients.

• Mounjaro contains tirzepatide and acts on GIP and GLP-1 receptors.
• Wegovy contains semaglutide and acts on GLP-1 receptors.
• Both require medical screening, gradual dose escalation, and long-term monitoring.

The appropriate medication depends on health history, local indication, availability, tolerance, and professional judgment.

Mounjaro vs. Fat-Dissolving Injections

These treatments have different purposes.

• Mounjaro supports overall metabolic and weight management.
• Fat-dissolving injections target small localized fat pockets.
• Body contouring improves selected body areas without major weight loss.
• Liposuction surgically removes localized fat.

Mounjaro cannot selectively reduce only the abdomen, arms, thighs, or double chin.

What Happens After Stopping Mounjaro?

Appetite may increase, and weight regain is possible after discontinuation.

A maintenance plan may include:

• Continued nutrition support
• Regular exercise
• Muscle preservation
• Weight monitoring
• Behavioral strategies
• Medication adjustment under medical guidance
• Periodic follow-up

Patients should not stop or restart tirzepatide without consulting the prescribing clinician.

Mounjaro for International Patients

International patients should provide:

• Current height and weight
• Current tirzepatide dose
• Date of the most recent injection
• Previous GLP-1 medication
• Diabetes treatment history
• Current prescriptions
• Recent laboratory results
• Arrival and departure dates

Medication brands, approved indications, dose presentations, and availability may differ between Korea and your home country. A continuation and monitoring plan should be arranged before departure.

Why Choose Sreborn Skin Clinic Hongdae?

Sreborn Skin Clinic Hongdae provides personalized medical weight-management care for Korean residents and international visitors in Hongdae, Hapjeong, and Seoul.

The program emphasizes:

• Medical eligibility assessment
• Authentic prescription medication
• Individualized dose progression
• Side-effect monitoring
• Nutrition and activity support
• Muscle-preservation planning
• Multilingual patient assistance
• Convenient Hongdae location

Frequently Asked Questions

Is Mounjaro a fat-dissolving injection?

No. Mounjaro is a prescription tirzepatide medication supporting overall metabolic and weight management.

How often is Mounjaro injected?

Use it only according to the schedule prescribed by your clinician and the instructions for your specific product.

Can I start with a high dose?

Treatment generally begins at a lower dose and increases gradually to reduce side effects.

Is Mounjaro the same as Wegovy?

No. Mounjaro contains tirzepatide, while Wegovy contains semaglutide.

Will I regain weight after stopping?

Weight regain is possible, particularly without nutrition, exercise, behavioral, and maintenance support.

Can I receive Mounjaro during a short visit to Korea?

Possibly, following medical assessment. You should also plan how prescriptions and monitoring will continue after returning home.

Book a Mounjaro Consultation in Hongdae

Contact Sreborn Skin Clinic Hongdae for a personalized tirzepatide eligibility assessment, prescription consultation, side-effect monitoring, and long-term weight-management plan.